NCT06666998
Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients
StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Clinical remission rate
Timeframe: At the end of treatment;2 weeks(estimated)
Microbiological efficacy
Timeframe: From enrollment to the end of treatment at 28 days
Secondary (1)
Develop Population Pharmacokinetic Model